Physicians may be able to identify individuals with preclinical type 1 diabetes, and to assess the effectiveness of therapies.
Read More »Diabetes In Control
Insulin Resistance Detectable 20 Years Before Type 2 Diabetes Onset
New Research now provides new information on the early steps in the development of IR and suggests why insulin-resistant people easily gain weight.
Read More »Hormone Linked to Sugar Control in Diabetics
High blood levels of a hormone called adiponectin are associated with improved sugar
Read More »U.S. FDA Refuses to Pull Abbott Obesity Drug Merida
The U.S. Food and Drug Administration rejected a consumer group’s petition to withdraw Abbott Laboratories Inc.’s obesity drug Meridia (sibutramine).
Read More »Diabetes Prolongs Fracture Recovery
Researchers have found that patients with diabetes who require surgery for ankle fractures have significantly higher rates of complications and higher hospital costs compared with non-diabetic patients.
Read More »Insulin Protects the Endothelium in the Critically Ill
Intensive insulin therapy safeguards the endothelium of critically ill patients and improves survival.
Read More »Nerve Autoantibodies Tied to Peripheral Autonomic Neuropathy in Diabetics
Autoantibodies directed against autonomic nerves are associated with the subsequent development of cardiac and peripheral autonomic neuropathy in diabetic patients.
Read More »Coffee-Diabetes Link Age, Weight Related
A link between consumption of coffee and caffeine and a risk of type-2 diabetes has been bandied about for some time, but a new research suggests that the relationship may be age- and weight-loss related.
Read More »Doctors Prompted by Trained Nurses Improves Rates of Counseling for Diabetes Pre
Doctors Prompted by Trained Nurses Improves Rates of Counseling for Diabetes PreventionInvolving nurses in diabetes prevention with simple prompts can lead to improved outcomes.
Read More »Sirolimus Heart Stent Improves Diabetic Patient Outcomes
Coronary arteries are less likely to reclog in patients who receive stents coated with the drug sirolimus (Cypher; Cordis, Johnson & Johnson) the results of three newly published studies suggest that the difference appears to be more pronounced in patients with diabetes.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.